Compare GNTA & BSIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | BSIN |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.7M | 53.4M |
| IPO Year | 2021 | 1995 |
| Metric | GNTA | BSIN |
|---|---|---|
| Price | $1.31 | $1.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.3K | ★ 1.6M |
| Earning Date | 03-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,379,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $1.00 |
| 52 Week High | $10.00 | $1.50 |
| Indicator | GNTA | BSIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 68.98 |
| Support Level | $1.28 | $1.09 |
| Resistance Level | $1.70 | $1.50 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 25.00 | 81.71 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.